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Summary
The majority of patients with 18q syndrome appear
cytogenetically to have a terminal deletion of the long
arm of chromosome 18. These 18q patients are di-
agnosed by use of standard cytogenetic banding tech-
niques, which have resolution insufficient for precise ge-
notyping. In our effort to obtain a thorough genotype,
we have analyzed the DNA from 35 patients who orig-
inally were diagnosed as having de novo terminal de-
letions of chromosome 18. Molecular analysis was per-
formed with polymorphic markers throughout the 18q
region. Cytogenetic FISH was performed with two hu-
man 18q telomeric probes, a chromosome 18–specific
a-satellite probe, and whole chromosome 18–specific
paint. Of 35 patients previously reported to have ter-
minal deletions of 18q, we found that 5 (14%) have
more-complex cryptic rearrangements and that 3 (9%)
retain the most distal portion of 18q, consistent with an
interstitial rather than a terminal deletion. These findings
indicate that a standard karyotype can lead to insuffi-
cient characterization in 18q syndrome. This has im-
portant ramifications for phenotype mapping of this syn-
drome, as well as for proper prognosis.
Introduction
The 18q syndrome is a partial aneusomy disorder re-
sulting from the deletion of a portion of the long arm
of chromosome 18. Since 1964, when it was first de-
scribed by de Grouchy et al. (1964), it has been found
to be one of the more common autosomal-chromosomal
deletion syndromes (Schinzel 1984). Patients with 18q
syndrome exhibit a wide range of features. Among the
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more common features are developmental delay, mental
retardation, incomplete myelination, microcephaly, fa-
cial and limb abnormalities, genitourinary malforma-
tions, neurological abnormalities, hearing abnormalities,
and growth failure (Schinzel 1984; Miller et al. 1990).
A more comprehensive list of clinical manifestations re-
veals a broad phenotypic spectrum with many other fea-
tures found less frequently (Strathdee et al. 1995). A
wide variability in clinical presentation of 18q syn-
drome is not surprising, since all known aneuploidies
are highly variable (Brown et al. 1993; Penny et al.
1995). This may be due to genetic background, imprint-
ing, extent (size and localization) of deletions, or other
chromosomal alterations. For other aneusomies, it has
been shown that chromosomal regions can be identified
and correlated with specific clinical presentations (Ko-
renberg et al. 1990; Penny et al. 1995). Such an effort
requires precise genotypic analysis coupled with exten-
sive clinical investigation.
Initial efforts to evaluate patients with 18q deletions
at the clinical, cytogenetic, and molecular levels, for the
purpose of phenotypic mapping, have already been re-
ported. Kline et al. (1993), using a molecular and cy-
togenetic approach, established a correlation between
the extent of deletion and the clinical picture in seven
patients. These correlations were not confirmed in the
evaluation, by the same group, of an additional 19 pa-
tients (Strathdee et al. 1995). These investigators also
have performed molecular analyses of the ends of the
deleted chromosomes (Strathdee et al. 1994, 1995) and
have found only terminal deletions in their patient pop-
ulation. Other investigators have identified, by cytoge-
netic means, individuals with interstitial deletions of 18q
(Wilson et al. 1979; Chudley et al. 1992; Krasikov et
al. 1992). It is important to determine whether deletions
are terminal or interstitial, because the ends of the chro-
mosomes have been found to be rich in transcribed se-
quences (Saccone et al. 1992). Physically small but tran-
scriptionally rich undetected terminal sequences can
greatly complicate phenotypic mapping.
In this report, we describe the results of detailed anal-
ysis performed on 35 patients previously reported, by
routine cytogenetic methods, to have terminal deletions
of 18q. To obtain a more precise genotype, we have used
Brkanac et al.: Cryptic Rearrangements of 18q 1501
molecular analysis, high-resolution G-banding, and
FISH to analyze our patients. We have found five in-
dividuals with more-complex cryptic rearrangements.
Detection of patients with complex structural abnor-
malities will result in both a more accurate prognosis
and a better understanding of the genetic heterogeneity
of this syndrome.
Patients and Methods
Patient Population
Patients were referred either by their individual phy-
sicians or from the Chromosome 18 Registry and Re-
search Society, a support group for families of individ-
uals with chromosome 18 abnormalities. The study was
approved by the institutional review board at the Uni-
versity of Texas Health Science Center at San Antonio,
and informed consent was obtained from all subjects.
PCR Amplification
Molecular analysis to confirm the deletions ofmaterial
from the long arm of chromosome 18 was performed
by use of PCR-based microsatellite markers (Dib et al.
1996). To obtain DNA for this analysis, blood samples
were obtained from the patient and both parents (when
available). High-molecular-weight genomic DNA was
extracted from the peripheral blood leukocytes by the
method of Bell et al. (1981). The DNA from each family
was analyzed by use of as many as 18 PCR-based mark-
ers. These markers were originally identified by Ge´ne´-
thon and have been placed in a linear order (Dib et al.
1996). PCR was performed in a total reaction volume
of 10 ml, with 50 ng of genomic DNA, 50 ng of each
primer, 200 mM of each dNTP, and 0.5 U of Taq poly-
merase (Perkin Elmer Cetus). Magnesium levels and an-
nealing temperatures were optimized for each set of
primers. One primer of each pair was end labeled at the
5′ end, with g[32P]- dATP. PCR amplification consisted
of 30 cycles of 1 min at 95C, followed by 1 min at the
appropriate annealing temperature and 1min elongation
at 72C. PCR products were separated on a 7% poly-
acrylamide gel run at 65W for 4–6 h and were visualized
by means of Kodak XAR-5 film with intensifying
screens.
Pulsed-Field Gel Electrophoresis
Agarose plugs containing DNA from the human telo-
meric YAC clone yRM2050 were prepared as described
elsewhere (Riethman et al. 1989; Dracopoli et al. 1994).
The samples were electrophoresed in 0.5# Tris-borate
EDTA buffer chilled to 14C, with a voltage gradient of
6 V/cm and a switch time of 30–45 s, for 23 h, with a
CHEF-DR III Pulsed Field Electrophoresis System (Bio-
Rad Laboratories). Gels were stained in ethidium bro-
mide and were visualized, and the band containing the
human insert DNA was excised. The YAC containing
the human DNA was purified from the gel by use of the
Prep-A-Gene DNA Purification System (Bio-Rad Labo-
ratories) and was quantified with a DNA Dip Stick Kit
(Invitrogen).
P1 Genomic-Clone Isolation
A human genomic P1 library constructed in Dr. Stern-
berg’s laboratory was obtained from DuPont (Shepherd
et al. 1994). This library is arrayed by the strategy first
described, by Green and Olson (1990), for YACs. It in-
cludes human inserts with a size range of 70–95 kb and
contains three to four genome equivalents. PCR primers
specific for the marker D18S553 were used to screen the
library for clones containing this sequence. This marker
is one of the most telomeric markers on chromosome
18q, mapping within the distal 270 kb of 18q, and is
contained within the human 18q half-YAC telomere
probe, yRM2050. A positive clone was isolated and ex-
panded, and DNA was isolated by use of a modified
Qiagen large-scale preparation (Qiagen; modified pro-
tocol obtained from Genome Systems).
FISH
Metaphase chromosome spreads were obtained either
from Epstein-Barr virus–transformed lymphocytes (An-
derson and Gusella 1984) or by primary blood harvest.
For blood harvest, preparations were made by standard
methods (Moorehead et al. 1960; Ikeuchi 1984), and a
similar protocol was used for lymphoblastoid lines (Gi-
bas and Jackson 1985). The YAC DNA and the P1 DNA
were labeled, by nick translation, with either biotin-14-
dATP (BRL/Gibco) or digoxigenin-11-dUTP (Boehringer
Mannheim Biochemical). Slides for FISH, prepared the
day before use, were baked for 4 h and were denatured
for 2 min (70% formamide and , pH 7.0). Hy-2# SSC
bridization buffer (50% formamide, 10% dextran sul-
fate, and , pH 7.0), human Cot-1 DNA, chro-2# SSC
mosome 18 a-satellite DNA (Oncor), and 40–100 ng of
telomere-region (YAC or P1) probe were mixed, dena-
tured for 5 min, and immediately added to slides. These
were allowed to hybridize by overnight incubation at
37C in a humid chamber. Slides were washed and flu-
orescently labeled the following day, by means of avidin-
conjugated fluorescein isothiocyanate (FITC). For two-
color FISH, avidin-conjugated Texas Red and digoxi-
genin-specific antibodies labeled with FITC were used
for labeling the probes. Amplification of the signal was
performed with biotinylated anti-avidin and avi-
din–Texas Red, for the biotin-labeled probe, and with
FITC-conjugated anti-sheep antibodies, for the digoxi-
genin probe. The chromosomes were counterstained
with 4′,6-diamidino-2-phenylindole dihydrochloride
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Table 1
Summary of Results from Five Patients with Cryptic Rearrangements
Patient 13 Patient 17 Patient 30 Patient 31 Patient 34
Molecular
analysis
Interstitial deletion
between D18S65
and D18S461
Terminal deletion
distal to D18S450
No confirmed
deletion
Interstitial deletion
between
D18S447 and
D18S70
Terminal deletion
distal to D18S69
High-resolution
G-banding
Terminal deletion
at q21.1 46,XX,
del(18)(q21.1)
Abnormal karyotype
46,XY,der(18)
add(18)(q21.3)
Terminal deletion
at q21.1 46,XX,
del(18)(q21.1)
Terminal deletion
at q23 46,XX,
del(18)(q23)
Abnormal karyotype
46,XY,der(18)
add(18)(q21.3)
Two-color FISH
with chromo-
some 18 cen-
tromere
(green) and
18q telomere
(red)
Two green centro-
mere signals, two
red terminal sig-
nals on each 18q,
interstitial deletion
on the normal 18q
Two green centromere
signals and an inter-
stitial green signal
on abnormal 18q,
one red interstitial
deletion, paracentric
inversion
Two green centro-
mere signals, two
red terminal sig-
nals on each 18q,
interstitial deletion
Two green centro-
mere signals,
two red terminal
signals on each
18q
Two green centromere
signals, one red ter-
minal signal on
normal 18q, termi-
nal deletion
Whole chromo-
some 18 paint
Entire chromosome
painted and no 18
signal elsewhere
Entire chromosome
painted with only
one centromere and
no 18 signal
elsewhere
Entire chromosome
painted and no 18
signal elsewhere
Entire chromo-
some painted
and no 18 signal
elsewhere
Entire chromosome
painted and no 18
signal elsewhere
(DAPI) and were viewed by means of a Zeiss Axioscop
fluorescent microscope equipped with FITC, DAPI,
Texas Red, and triple-bandpass filter sets. Images were
captured by a computer using Applied Imaging Prob-
evision software, and photographs were printed on a
Kodak XL 7700 color-image printer. The chromosome
18 paint probe (Cambio) was applied according to the
manufacturer’s protocol, except that only 2 ml of the
probe was used. For each patient, 120 cells were
screened either for the presence of 18q telomeric se-
quences or for paint distribution.
Cytogenetics
Chromosomes were prepared, in themanner described
above, for prometaphase spreads. The chromosome-
banding level was determined by the method of Josifek
et al. (1991). For each patient, x20 metaphase spreads
were counted, and 10 of them, with a band level x550,
were analyzed on the microscope. A minimum of five
spreads were photographed, and two were karyotyped.
Results
High-resolution G-banding was performed on all
18q patients in our study who either had been referred
to us without a cytogenetic report, had a previous cy-
togenetic report that was of insufficient quality, and/or
had undergone molecular analysis that showed large un-
informative regions. From this analysis, two patients
(patients 17 and 34) were found to have cryptic rear-
rangements. The results of the G-banding studies are
described below and are summarized in table 1.
To estimate a proximal breakpoint location, genomic
DNA from the 35 families that we studied was analyzed
by use of x18 polymorphic PCR-based markers dis-
tributed throughout the 18q region. Multiple markers
along the long arm were used to confirm absence of a
copy of chromosome 18 material. All 35 patient samples
were analyzed with the most distally placed marker,
D18S70 (also known as “D18S497”), which maps
within the distal 270 kb of 18q and is contained within
the human 18q half-YAC clone yRM2050. The DNA
samples from 24 patients were informative, and 3 (pa-
tients 13, 30, and 31) retained two copies of the marker.
The results of the molecular analysis of these three pa-
tients are summarized in figure 1 and table 1, along with
those for patients 17 and 34. The 11 patients uninform-
ative by molecular analysis with the telomeric PCR
marker, a group that included patient 17, were further
analyzed by FISH with the half-YAC telomere probe,
yRM2050. This analysis revealed no additional patients
with interstitial deletions (data not shown).
The five patients identified with apparentlymore-com-
plicated rearrangements (patients 13, 17, 30, 31, and
34) were studied in greater detail, in order to determine
a more precise genotype. Both FISH analysis using two-
color FISH with centromere and telomere probes and
FISH analysis with whole chromosome 18 paint probe
were used to confirm and clarify the previous molecular
and cytogenetic findings. The results of these studies for
each of our five novel patients are shown in figure 2 and
are summarized in table 1. In each section of the figure,
the “abnormal” chromosome is on the left, and the “nor-
mal” chromosome is on the right. Figure 2A shows the
results of the high-resolution G-banding. Figure 2B
shows the results of two-color FISH with chromosome
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Figure 1 Molecular analysis of five patients with chromosome 18 deletions, by use of polymorphic markers. A blackened oval indicates
that there are two alleles for the corresponding marker; an unblackened oval indicates that the subject has a single allele; and a dash indicates
that the marker was uninformative.
18–specific a-satellite probe and the human genomic P1
telomere probe, D18S553. This analysis was done to
confirm the presence or absence of telomere sequences
in these patients. Figure 2C shows the chromosome 18s
from our five patients examined with whole chromo-
some 18–specific paint probe (WCP-18). This analysis
verifies that these more complex rearranged chromo-
somes contain only chromosome 18 material and that
no chromosome 18 material was translocated elsewhere
in the metaphase (data not shown).
Two patients (patients 13 and 31) were found, by
molecular analysis, to have interstitial deletions but ap-
peared, by high-resolution G-banding, to have terminal
deletions—46,XX,del(18)(q21.1) and 46,XY,del(18)
(q23), respectively—of the long arm of chromosome 18.
For patient 30, the cytogenetic analysis proved especially
useful, since molecular analysis was uninformative for
a large region of chromosome 18 and could not confirm
any loss of material from this region. The deleted chro-
mosome was found to have a large terminal dele-
tion—46,XX,del(18)(q21.1)—at band q21.1. The anal-
ysis of the “normal” chromosome 18 has been more
difficult. This chromosome demonstrated an apparently
normal banding pattern with a lighter intensity andmore
diffuse pattern of the terminal bands.
When the chromosomes of these patients were ana-
lyzed by two-color FISH, each patient displayed two
telomere fluorescent signals and two centromeric signals,
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Figure 2 Cytogenetic and FISH analysis of five patients (identified by the numbers above the chromosome pairs) with chromosome 18
deletions. A, High-resolution G-banding. B, FISH using FITC-labeled human chromosome 18–specific a-satellite probe (green) and Texas
Red–labeled human P1 genomic clone (red), containing the chromosome 18 telomeric marker D18S553 as the other probe. C, FISH with
chromosome 18–specific paint labeled with FITC (green). All FISH-labeled chromosomes are counterstained with DAPI (blue).
confirming the molecular data. Therefore, these patients
proved to have interstitial, rather than terminal, dele-
tions. FISH analysis of these five patients with WCP-18
showed only chromosome 18–specific material present
on each of the chromosomes, with no chromosome 18
material present elsewhere in the metaphase (data not
shown). The “normal” chromosome 18 from patient 30
had an odd “two blob” appearance when whole chro-
mosome 18–specific paint was used, an appearance very
much unlike the staining for other normal chromosomes.
Further analysis will be needed to determine whether
there is an abnormality of this chromosome.
Chromosomes from patients 17 and 34 were found,
on the basis of molecular data, to be simple terminal
deletions. High-resolution G-banding determined that
both were derivative chromosomes from translocations
of chromosome 18 with another unknown chromo-
some—46,XY,der(18)add(18)(q21.3) and 46,XX,der
(18)add(18)(q21.3), respectively. The abnormal chro-
mosome from both patients appeared to have large de-
letions of chromosome 18 material and a wide, euchro-
matic band at the distal end of the q arm. The two-color
FISH analysis of each patient revealed only one copy of
the telomere probe, and this was found on the normal
chromosome. For patient 17, no telomeric sequences
were present on the deleted chromosome, since the mo-
lecular analysis was uninformative for this region. One
interesting finding was the interstitial localization of a
small amount of chromosome 18–specific a-satellite se-
quence on the long arm of the deleted chromosome of
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patient 17. When chromosomes of these two patients
were studied with WCP-18, only chromosome 18 ma-
terial was present on the chromosomes 18, and no chro-
mosome 18 material was seen elsewhere in the meta-
phase (data not shown). For patient 17, only one
centromere was observed in the abnormal chromosome,
as demonstrated by only one region of blocked highly
repetitive sequence. This indicates that the extra a-sat-
ellite material in the long arm is not associated with a
duplication of the centromere. These results, as well as
the size of each derivative chromosome, indicate that
each chromosome must also have a partial duplication
of chromosome 18 material.
Discussion
We have described molecular and cytogenetic char-
acterization of patients with 18q syndrome, which is
the sine qua non for phenotypic mapping. Our initial
population of 35 patients was referred to us because, by
routine cytogenetic methods, they had terminal deletions
of 18q. We have reassessed each of these patients by
complementary molecular and cytogenetic techniques, to
accomplish precise genotypic analysis. Five (14%) of
these 35 patients proved to have more-complex cryptic
rearrangements.
Three (9%) of the 35 patients retained chromosome
18 telomeric material, as shown by molecular and FISH
analysis. Telomeres are known to be rich in transcrip-
tionally active material (Saccone et al. 1992); therefore,
small amounts of telomeric genomic material could con-
tain numerous genes and thus greatly influence pheno-
typic variability. In addition, the shorter chromosome
18 of patient 17 was found, by FISH studies, to have
a-satellite sequences positioned interstitially and not in
association with a duplicated centromere. This suggests
an inversion or an insertion of chromosome 18. Further
studies are underway to determine the exact nature of
this chromosome abnormality.
Using various techniques, we have identified two pa-
tients (patients 17 and 34) for whom molecular studies
indicated large deletions, in contrast with the small dif-
ferences that were noted in the sizes of the normal and
abnormal chromosomes by high-resolution G-banding.
FISH with chromosome 18–specific paint proved that
the abnormal chromosomes contain only chromosome
18–specific material, suggesting a duplication of part of
chromosome 18. These patients cannot be used for the
phenotypic mapping of the deletion syndromes. Patient
30 will also be excluded, since cytogenetic analysis re-
vealed a large terminal deletion whereas molecular anal-
ysis was uninformative for much of the region of interest.
In addition, the “normal” chromosome in the patient
requires further characterization.
Our finding that some of the terminal deletions iden-
tified by routine cytogenetic examinations are actually
interstitial deletions contrasts with the results reported
by Strathdee et al. (1995), who found that all 26 of their
patients with 18q syndrome had terminal deletions.
This is most likely explained by the small sample size
and the differences in study populations, although we
are aware of some overlap in our patients.
In a group of 35 patients previously reported to have
terminal deletions of 18q, we have shown that 5 (14%)
contain more-complex cryptic rearrangements. We have
also shown that high-resolution karyotype analysis and
molecular analysis are both necessary for accurate ge-
notype analysis. Three (9%) of our group of 35 patients
would have been incorrectly genotyped by molecular
analysis alone, and all 5 subjects would have been in-
completely genotyped by high-resolution cytogenetics
alone. FISH analysis was required for the detection of
the possible paracentric inversion or insertion and of the
presence of only chromosome 18 material in the two
cases in which translocations were suspected. Correla-
tion of genotype with phenotype will require use of pre-
cise genotypic analysis with these complementary tech-
niques. Small duplications of material, similar to those
found in two of our patients, would cause trisomy of
that chromosomal region. This would be highly detri-
mental to the phenotype, and the inclusion of such pa-
tients would confuse any phenotypic mapping attempts.
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